Your browser doesn't support javascript.
loading
The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways.
Sultan, Muthanna; Alghetaa, Hasan; Mohammed, Amirah; Abdulla, Osama A; Wisniewski, Paul J; Singh, Narendra; Nagarkatti, Prakash; Nagarkatti, Mitzi.
Afiliación
  • Sultan M; Department of Pathology, Microbiology and Immunology, School of Medicine, University of SC, Columbia, SC, United States.
  • Alghetaa H; Department of Pathology, Microbiology and Immunology, School of Medicine, University of SC, Columbia, SC, United States.
  • Mohammed A; Department of Pathology, Microbiology and Immunology, School of Medicine, University of SC, Columbia, SC, United States.
  • Abdulla OA; Department of Pathology, Microbiology and Immunology, School of Medicine, University of SC, Columbia, SC, United States.
  • Wisniewski PJ; Department of Pathology, Microbiology and Immunology, School of Medicine, University of SC, Columbia, SC, United States.
  • Singh N; Department of Pathology, Microbiology and Immunology, School of Medicine, University of SC, Columbia, SC, United States.
  • Nagarkatti P; Department of Pathology, Microbiology and Immunology, School of Medicine, University of SC, Columbia, SC, United States.
  • Nagarkatti M; Department of Pathology, Microbiology and Immunology, School of Medicine, University of SC, Columbia, SC, United States.
Front Pharmacol ; 12: 644281, 2021.
Article en En | MEDLINE | ID: mdl-33995054

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza